Treatment for Shingles (Herpes Zoster) Affecting the Cerebrospinal Fluid
For herpes zoster affecting the cerebrospinal fluid, intravenous acyclovir 10 mg/kg every 8 hours should be administered for 14-21 days. 1
Diagnosis and Clinical Presentation
- Herpes zoster affecting the CSF typically presents as meningitis with signs including headache, photophobia, fever, and meningismus 1
- CSF analysis usually shows lymphocytic pleocytosis, mildly elevated protein, and normal glucose 1
- CSF PCR for VZV should be obtained to confirm the diagnosis 1
- It's critical to distinguish between VZV meningitis and encephalitis, as encephalitis is a more severe condition with potential for high neurologic morbidity and mortality 1
Treatment Recommendations
Acute Treatment
- For confirmed VZV affecting the CSF:
Monitoring During Treatment
- Monitor CSF pressure, as elevated intracranial pressure may require intervention 1
- Consider repeat CSF analysis at the end of therapy to confirm clearance of the virus, especially if clinical response is suboptimal 1
- If CSF PCR remains positive after treatment course, antiviral therapy should be continued 1
Special Considerations
For immunocompromised patients:
For patients with ocular involvement:
Management of Complications
Elevated Intracranial Pressure
- If CSF pressure is ≥25 cm of CSF and there are symptoms of increased intracranial pressure:
- Perform CSF drainage via lumbar puncture 1
- Reduce opening pressure by 50% if extremely high or to a normal pressure of ≤20 cm of CSF 1
- For persistent pressure elevation, repeat lumbar puncture daily until pressure and symptoms stabilize 1
- Consider temporary percutaneous lumbar drains or ventriculostomy for patients requiring repeated daily lumbar punctures 1
Recurrent Episodes
- For recurrent episodes of VZV meningitis:
Post-Treatment Follow-up
- Follow patients clinically after completion of therapy 1
- Monitor for potential neurological sequelae 1, 3
- Assess for any signs of recurrence, which may require additional treatment 1
Adjunctive Therapies
- Corticosteroids may be considered in VZV vasculopathy to reduce inflammation 2
- For pain management:
Prevention of Recurrence
- Long-term suppressive therapy has not been well-studied for VZV affecting the CSF 5
- Vaccination against herpes zoster may be considered for prevention in eligible patients after recovery 6
Pitfalls and Caveats
- Failure to distinguish between meningitis and encephalitis can lead to inadequate treatment duration 1
- Delayed initiation of antiviral therapy is associated with worse outcomes 1
- Relapse can occur after completion of therapy, requiring vigilant follow-up 1
- Steroid use should be carefully considered and not used routinely without specific indications 1